|
NUP133 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96372999999861E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.93880000000291E-05 |
| Normal-vs-Stage2 |
3.121100E-03 |
| Normal-vs-Stage3 |
4.35429999999792E-05 |
| Normal-vs-Stage4 |
7.161400E-04 |
| Stage1-vs-Stage2 |
8.262200E-01 |
| Stage1-vs-Stage3 |
6.585000E-01 |
| Stage1-vs-Stage4 |
7.180200E-01 |
| Stage2-vs-Stage3 |
6.239400E-01 |
| Stage2-vs-Stage4 |
6.724800E-01 |
| Stage3-vs-Stage4 |
9.764800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.83010000000183E-05 |
| Normal-vs-AfricanAmerican |
4.959400E-01 |
| Normal-vs-Asian |
2.220700E-04 |
| Caucasian-vs-AfricanAmerican |
2.816300E-02 |
| Caucasian-vs-Asian |
6.980400E-01 |
| AfricanAmerican-vs-Asian |
2.430000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.69290000000034E-05 |
| Normal-vs-Female |
3.66539999999693E-05 |
| Male-vs-Female |
5.711000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.821210E-04 |
| Normal-vs-Age(41-60Yrs) |
2.20469999999695E-05 |
| Normal-vs-Age(61-80Yrs) |
8.214000E-04 |
| Normal-vs-Age(81-100Yrs) |
4.304100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.255400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.351400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.869400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.362200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.505800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.681000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.277800E-02 |
| Classical-VS-Follicular |
7.828100E-04 |
| Classical-VS-Other |
7.510300E-02 |
| Classical-VS-Normal |
1.642920E-03 |
| Tall-VS-Follicular |
4.514600E-01 |
| Tall-VS-Other |
2.259600E-01 |
| Tall-VS-Normal |
2.648200E-04 |
| Follicular-VS-Other |
5.030600E-01 |
| Follicular-VS-Normal |
2.02069999954979E-07 |
| Other-VS-Normal |
1.960160E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.69960000004654E-06 |
| Normal-vs-N1 |
3.6811000000414E-06 |
| N0-vs-N1 |
2.164000E-01 |
|
|
